Identifying Novel Targets for Nutritional Therapy in Canine Sepsis
Sepsis is a life-threatening consequence of a dysregulated response to infection that results in organ damage. Small trials in people with sepsis have shown that targeted nutritional support reduces organ dysfunction, hospital-acquired infections, and death. We plan to use sophisticated mass spectrometry techniques to better understand the metabolic changes that occur in canine sepsis. We hope this will enable us to identify new targets for nutritional therapies.
Eligibility: Any dog admitted to the Cornell University Hospital for Animals diagnosed with sepsis due to bacterial infections. Patients must not have other metabolic diseases such as diabetes.
Compensation: There is no extra cost to you to participate in this study. Any tests or procedures unrelated to the study will be your responsibility.
Owner Responsibilities: If you agree to allow your dog to participate in this study, your dog will receive the same diagnostic tests and treatments as for any other dog with this disease and will receive standard of care therapies. We will draw approximately a teaspoon of extra blood at admission.
Principal Investigator: Robert Goggs, BVSc, DACVECC, DECVECC, PhD, MRCVS
Contact/Schedule an Appointment: Please contact the emergency service or the clinical trials coordinator at 607.253.3060, or email firstname.lastname@example.org. Your referring veterinarian may also contact the hospital to refer your pet.